Foreign Currency Exchange. For any currency conversion from the currency of one country in which Licensed Products are sold into United States dollars (or another currency if applicable) required in determining the amount of Net Sales or any royalties due hereunder, such conversion shall be calculated at the conversion rate as reported in the Wall Street Journal (New York Edition) (or if that is no longer published, at the exchange rate reported by The Bank of Tokyo-Mitsubishi UFJ, Ltd.) on the last Business Day of the applicable quarterly period in which the Net Sales are determined.
Appears in 3 contracts
Samples: Exclusive License and Supply Agreement (Reata Pharmaceuticals Inc), Exclusive License and Supply Agreement (Reata Pharmaceuticals Inc), Exclusive License and Supply Agreement (Reata Pharmaceuticals Inc)
Foreign Currency Exchange. For any currency conversion from the currency of one country in which Licensed Products are sold into United States dollars (or another currency if applicable) required in determining the amount of Net Sales or any royalties Royalties due hereunder, such conversion shall be calculated at the conversion rate as reported in the The Wall Street Journal (New York Edition) (or if that is no longer published, at the exchange interbank rate reported quoted by The Bank of Tokyo-Mitsubishi UFJCitibank, Ltd.N.A.) on the last Business Day of the applicable quarterly period in which the Net Sales are determined.
Appears in 1 contract
Foreign Currency Exchange. For any currency conversion from the currency of one country in which the Licensed Products are sold into United States dollars U.S. Dollars (or another currency if applicable) required in determining the amount of Net Sales or any royalties due hereunderor revenue share, such conversion shall be equal to the average exchange rate, over the applicable quarter, calculated at the conversion rate as reported in by OANDA (xxx.xxxxx.xxx), or an equivalent resource as agreed by the Wall Street Journal (New York Edition) (or if that is no longer publishedparties, at the exchange rate reported by The Bank of Tokyo-Mitsubishi UFJ, Ltd.) on the last Business Day of the applicable quarterly period quarter in which the applicable Net Sales are determinedwere made.β
10. A new Section 7.8 shall be added that provides as follows:
Appears in 1 contract
Samples: Collaboration and License Agreement (Ultragenyx Pharmaceutical Inc.)